Nkarta (NKTX) Operating Leases (2019 - 2026)

Nkarta's quarterly Operating Leases came in at $67.9 million in Q1 2026, down 6.91% year-on-year from $73.0 million in Q1 2025, and down 2.32% quarter-over-quarter from $69.5 million in Q4 2025.

Nkarta has reported Operating Leases for 8 years, with the latest figure at $67.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 6.91% year-over-year to $67.9 million; the trailing twelve-month figure through Mar 2026 stood at $67.9 million (down 6.91% YoY), and the FY2025 full-year result was $69.5 million, down 6.32% from the prior year.
  • Operating Leases for Q1 2026 stood at $67.9 million, down from $69.5 million in the prior quarter.
  • The five-year high for Operating Leases was $85.5 million in Q1 2023, with the low at $66.7 million in Q1 2022.
  • Average Operating Leases over 5 years is $76.2 million, with a median of $78.1 million recorded in 2022.
  • Year-over-year, Operating Leases soared 688.82% in 2022 and fell 10.72% in 2025.
  • Tracing NKTX's Operating Leases over 5 years: stood at $78.7 million in 2022, then gained by 4.56% to $82.3 million in 2023, then fell by 9.78% to $74.2 million in 2024, then fell by 6.32% to $69.5 million in 2025, then retreated by 2.32% to $67.9 million in 2026.
  • The last three Operating Leases figures came in at $67.9 million (Q1 2026), $69.5 million (Q4 2025), and $70.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Nkarta 232.80 Mn 232.80 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 67.92 Mn
Dec 31, 2025 69.53 Mn
Sep 30, 2025 70.26 Mn
Jun 30, 2025 71.63 Mn
Mar 31, 2025 72.96 Mn
Dec 31, 2024 74.22 Mn
Sep 30, 2024 78.69 Mn
Jun 30, 2024 80.04 Mn
Mar 31, 2024 81.10 Mn
Dec 31, 2023 82.27 Mn
Sep 30, 2023 83.41 Mn
Jun 30, 2023 84.45 Mn
Mar 31, 2023 85.54 Mn
Dec 31, 2022 78.69 Mn
Sep 30, 2022 78.11 Mn
Jun 30, 2022 69.41 Mn
Mar 31, 2022 66.74 Mn
Dec 31, 2021 9.98 Mn
Sep 30, 2021 10.35 Mn
Jun 30, 2021 10.41 Mn
Mar 31, 2021 10.27 Mn
Dec 31, 2020 7.52 Mn
Sep 30, 2020 7.66 Mn
Jun 30, 2020 7.83 Mn
Dec 31, 2019 5.78 Mn